1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Venous Thromboembolism Therapy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Venous Thromboembolism Therapy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Venous Thromboembolism Therapy by Country/Region, 2018, 2022 & 2029
2.2 Venous Thromboembolism Therapy Segment by Type
2.2.1 Non-Segmented Pneumatic Compression Pumps
2.2.2 Segmented Pneumatic Compression Pumps without Gradient
2.3 Venous Thromboembolism Therapy Sales by Type
2.3.1 Global Venous Thromboembolism Therapy Sales Market Share by Type (2018-2023)
2.3.2 Global Venous Thromboembolism Therapy Revenue and Market Share by Type (2018-2023)
2.3.3 Global Venous Thromboembolism Therapy Sale Price by Type (2018-2023)
2.4 Venous Thromboembolism Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Venous Thromboembolism Therapy Sales by Application
2.5.1 Global Venous Thromboembolism Therapy Sale Market Share by Application (2018-2023)
2.5.2 Global Venous Thromboembolism Therapy Revenue and Market Share by Application (2018-2023)
2.5.3 Global Venous Thromboembolism Therapy Sale Price by Application (2018-2023)
3 Global Venous Thromboembolism Therapy by Company
3.1 Global Venous Thromboembolism Therapy Breakdown Data by Company
3.1.1 Global Venous Thromboembolism Therapy Annual Sales by Company (2018-2023)
3.1.2 Global Venous Thromboembolism Therapy Sales Market Share by Company (2018-2023)
3.2 Global Venous Thromboembolism Therapy Annual Revenue by Company (2018-2023)
3.2.1 Global Venous Thromboembolism Therapy Revenue by Company (2018-2023)
3.2.2 Global Venous Thromboembolism Therapy Revenue Market Share by Company (2018-2023)
3.3 Global Venous Thromboembolism Therapy Sale Price by Company
3.4 Key Manufacturers Venous Thromboembolism Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Venous Thromboembolism Therapy Product Location Distribution
3.4.2 Players Venous Thromboembolism Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Venous Thromboembolism Therapy by Geographic Region
4.1 World Historic Venous Thromboembolism Therapy Market Size by Geographic Region (2018-2023)
4.1.1 Global Venous Thromboembolism Therapy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Venous Thromboembolism Therapy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Venous Thromboembolism Therapy Market Size by Country/Region (2018-2023)
4.2.1 Global Venous Thromboembolism Therapy Annual Sales by Country/Region (2018-2023)
4.2.2 Global Venous Thromboembolism Therapy Annual Revenue by Country/Region (2018-2023)
4.3 Americas Venous Thromboembolism Therapy Sales Growth
4.4 APAC Venous Thromboembolism Therapy Sales Growth
4.5 Europe Venous Thromboembolism Therapy Sales Growth
4.6 Middle East & Africa Venous Thromboembolism Therapy Sales Growth
5 Americas
5.1 Americas Venous Thromboembolism Therapy Sales by Country
5.1.1 Americas Venous Thromboembolism Therapy Sales by Country (2018-2023)
5.1.2 Americas Venous Thromboembolism Therapy Revenue by Country (2018-2023)
5.2 Americas Venous Thromboembolism Therapy Sales by Type
5.3 Americas Venous Thromboembolism Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Venous Thromboembolism Therapy Sales by Region
6.1.1 APAC Venous Thromboembolism Therapy Sales by Region (2018-2023)
6.1.2 APAC Venous Thromboembolism Therapy Revenue by Region (2018-2023)
6.2 APAC Venous Thromboembolism Therapy Sales by Type
6.3 APAC Venous Thromboembolism Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Venous Thromboembolism Therapy by Country
7.1.1 Europe Venous Thromboembolism Therapy Sales by Country (2018-2023)
7.1.2 Europe Venous Thromboembolism Therapy Revenue by Country (2018-2023)
7.2 Europe Venous Thromboembolism Therapy Sales by Type
7.3 Europe Venous Thromboembolism Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Venous Thromboembolism Therapy by Country
8.1.1 Middle East & Africa Venous Thromboembolism Therapy Sales by Country (2018-2023)
8.1.2 Middle East & Africa Venous Thromboembolism Therapy Revenue by Country (2018-2023)
8.2 Middle East & Africa Venous Thromboembolism Therapy Sales by Type
8.3 Middle East & Africa Venous Thromboembolism Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Venous Thromboembolism Therapy
10.3 Manufacturing Process Analysis of Venous Thromboembolism Therapy
10.4 Industry Chain Structure of Venous Thromboembolism Therapy
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Venous Thromboembolism Therapy Distributors
11.3 Venous Thromboembolism Therapy Customer
12 World Forecast Review for Venous Thromboembolism Therapy by Geographic Region
12.1 Global Venous Thromboembolism Therapy Market Size Forecast by Region
12.1.1 Global Venous Thromboembolism Therapy Forecast by Region (2024-2029)
12.1.2 Global Venous Thromboembolism Therapy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Venous Thromboembolism Therapy Forecast by Type
12.7 Global Venous Thromboembolism Therapy Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Venous Thromboembolism Therapy Product Portfolios and Specifications
13.1.3 Medtronic Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Venous Thromboembolism Therapy Product Portfolios and Specifications
13.2.3 Boston Scientific Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Stryker
13.3.1 Stryker Company Information
13.3.2 Stryker Venous Thromboembolism Therapy Product Portfolios and Specifications
13.3.3 Stryker Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Stryker Main Business Overview
13.3.5 Stryker Latest Developments
13.4 AngioDynamics
13.4.1 AngioDynamics Company Information
13.4.2 AngioDynamics Venous Thromboembolism Therapy Product Portfolios and Specifications
13.4.3 AngioDynamics Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AngioDynamics Main Business Overview
13.4.5 AngioDynamics Latest Developments
13.5 Cook Medical
13.5.1 Cook Medical Company Information
13.5.2 Cook Medical Venous Thromboembolism Therapy Product Portfolios and Specifications
13.5.3 Cook Medical Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cook Medical Main Business Overview
13.5.5 Cook Medical Latest Developments
13.6 Cardinal Health
13.6.1 Cardinal Health Company Information
13.6.2 Cardinal Health Venous Thromboembolism Therapy Product Portfolios and Specifications
13.6.3 Cardinal Health Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cardinal Health Main Business Overview
13.6.5 Cardinal Health Latest Developments
13.7 DJO Global
13.7.1 DJO Global Company Information
13.7.2 DJO Global Venous Thromboembolism Therapy Product Portfolios and Specifications
13.7.3 DJO Global Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 DJO Global Main Business Overview
13.7.5 DJO Global Latest Developments
13.8 Philips Holding
13.8.1 Philips Holding Company Information
13.8.2 Philips Holding Venous Thromboembolism Therapy Product Portfolios and Specifications
13.8.3 Philips Holding Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Philips Holding Main Business Overview
13.8.5 Philips Holding Latest Developments
13.9 ArjoHuntleigh AB
13.9.1 ArjoHuntleigh AB Company Information
13.9.2 ArjoHuntleigh AB Venous Thromboembolism Therapy Product Portfolios and Specifications
13.9.3 ArjoHuntleigh AB Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ArjoHuntleigh AB Main Business Overview
13.9.5 ArjoHuntleigh AB Latest Developments
13.10 Argon Medical Devices
13.10.1 Argon Medical Devices Company Information
13.10.2 Argon Medical Devices Venous Thromboembolism Therapy Product Portfolios and Specifications
13.10.3 Argon Medical Devices Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Argon Medical Devices Main Business Overview
13.10.5 Argon Medical Devices Latest Developments
13.11 DaeSung Maref
13.11.1 DaeSung Maref Company Information
13.11.2 DaeSung Maref Venous Thromboembolism Therapy Product Portfolios and Specifications
13.11.3 DaeSung Maref Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 DaeSung Maref Main Business Overview
13.11.5 DaeSung Maref Latest Developments
13.12 ALN Implants Chirurgicaux
13.12.1 ALN Implants Chirurgicaux Company Information
13.12.2 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Product Portfolios and Specifications
13.12.3 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ALN Implants Chirurgicaux Main Business Overview
13.12.5 ALN Implants Chirurgicaux Latest Developments
13.13 Lifetech Scientific
13.13.1 Lifetech Scientific Company Information
13.13.2 Lifetech Scientific Venous Thromboembolism Therapy Product Portfolios and Specifications
13.13.3 Lifetech Scientific Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Lifetech Scientific Main Business Overview
13.13.5 Lifetech Scientific Latest Developments
14 Research Findings and Conclusion
Table 1. Venous Thromboembolism Therapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Venous Thromboembolism Therapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Non-Segmented Pneumatic Compression Pumps
Table 4. Major Players of Segmented Pneumatic Compression Pumps without Gradient
Table 5. Global Venous Thromboembolism Therapy Sales by Type (2018-2023) & (K Units)
Table 6. Global Venous Thromboembolism Therapy Sales Market Share by Type (2018-2023)
Table 7. Global Venous Thromboembolism Therapy Revenue by Type (2018-2023) & ($ million)
Table 8. Global Venous Thromboembolism Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global Venous Thromboembolism Therapy Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Venous Thromboembolism Therapy Sales by Application (2018-2023) & (K Units)
Table 11. Global Venous Thromboembolism Therapy Sales Market Share by Application (2018-2023)
Table 12. Global Venous Thromboembolism Therapy Revenue by Application (2018-2023)
Table 13. Global Venous Thromboembolism Therapy Revenue Market Share by Application (2018-2023)
Table 14. Global Venous Thromboembolism Therapy Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Venous Thromboembolism Therapy Sales by Company (2018-2023) & (K Units)
Table 16. Global Venous Thromboembolism Therapy Sales Market Share by Company (2018-2023)
Table 17. Global Venous Thromboembolism Therapy Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Venous Thromboembolism Therapy Revenue Market Share by Company (2018-2023)
Table 19. Global Venous Thromboembolism Therapy Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Venous Thromboembolism Therapy Producing Area Distribution and Sales Area
Table 21. Players Venous Thromboembolism Therapy Products Offered
Table 22. Venous Thromboembolism Therapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Venous Thromboembolism Therapy Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Venous Thromboembolism Therapy Sales Market Share Geographic Region (2018-2023)
Table 27. Global Venous Thromboembolism Therapy Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Venous Thromboembolism Therapy Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Venous Thromboembolism Therapy Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Venous Thromboembolism Therapy Sales Market Share by Country/Region (2018-2023)
Table 31. Global Venous Thromboembolism Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Venous Thromboembolism Therapy Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Venous Thromboembolism Therapy Sales by Country (2018-2023) & (K Units)
Table 34. Americas Venous Thromboembolism Therapy Sales Market Share by Country (2018-2023)
Table 35. Americas Venous Thromboembolism Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Venous Thromboembolism Therapy Revenue Market Share by Country (2018-2023)
Table 37. Americas Venous Thromboembolism Therapy Sales by Type (2018-2023) & (K Units)
Table 38. Americas Venous Thromboembolism Therapy Sales by Application (2018-2023) & (K Units)
Table 39. APAC Venous Thromboembolism Therapy Sales by Region (2018-2023) & (K Units)
Table 40. APAC Venous Thromboembolism Therapy Sales Market Share by Region (2018-2023)
Table 41. APAC Venous Thromboembolism Therapy Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Venous Thromboembolism Therapy Revenue Market Share by Region (2018-2023)
Table 43. APAC Venous Thromboembolism Therapy Sales by Type (2018-2023) & (K Units)
Table 44. APAC Venous Thromboembolism Therapy Sales by Application (2018-2023) & (K Units)
Table 45. Europe Venous Thromboembolism Therapy Sales by Country (2018-2023) & (K Units)
Table 46. Europe Venous Thromboembolism Therapy Sales Market Share by Country (2018-2023)
Table 47. Europe Venous Thromboembolism Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Venous Thromboembolism Therapy Revenue Market Share by Country (2018-2023)
Table 49. Europe Venous Thromboembolism Therapy Sales by Type (2018-2023) & (K Units)
Table 50. Europe Venous Thromboembolism Therapy Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Venous Thromboembolism Therapy Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Venous Thromboembolism Therapy Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Venous Thromboembolism Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Venous Thromboembolism Therapy Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Venous Thromboembolism Therapy Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Venous Thromboembolism Therapy Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Venous Thromboembolism Therapy
Table 58. Key Market Challenges & Risks of Venous Thromboembolism Therapy
Table 59. Key Industry Trends of Venous Thromboembolism Therapy
Table 60. Venous Thromboembolism Therapy Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Venous Thromboembolism Therapy Distributors List
Table 63. Venous Thromboembolism Therapy Customer List
Table 64. Global Venous Thromboembolism Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Venous Thromboembolism Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Venous Thromboembolism Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Venous Thromboembolism Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Venous Thromboembolism Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Venous Thromboembolism Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Venous Thromboembolism Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Venous Thromboembolism Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Venous Thromboembolism Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Venous Thromboembolism Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Venous Thromboembolism Therapy Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Venous Thromboembolism Therapy Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Venous Thromboembolism Therapy Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Venous Thromboembolism Therapy Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 80. Medtronic Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Boston Scientific Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 84. Boston Scientific Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 85. Boston Scientific Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Boston Scientific Main Business
Table 87. Boston Scientific Latest Developments
Table 88. Stryker Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 89. Stryker Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 90. Stryker Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Stryker Main Business
Table 92. Stryker Latest Developments
Table 93. AngioDynamics Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 94. AngioDynamics Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 95. AngioDynamics Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. AngioDynamics Main Business
Table 97. AngioDynamics Latest Developments
Table 98. Cook Medical Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 99. Cook Medical Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 100. Cook Medical Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Cook Medical Main Business
Table 102. Cook Medical Latest Developments
Table 103. Cardinal Health Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 104. Cardinal Health Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 105. Cardinal Health Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Cardinal Health Main Business
Table 107. Cardinal Health Latest Developments
Table 108. DJO Global Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 109. DJO Global Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 110. DJO Global Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. DJO Global Main Business
Table 112. DJO Global Latest Developments
Table 113. Philips Holding Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 114. Philips Holding Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 115. Philips Holding Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Philips Holding Main Business
Table 117. Philips Holding Latest Developments
Table 118. ArjoHuntleigh AB Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 119. ArjoHuntleigh AB Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 120. ArjoHuntleigh AB Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. ArjoHuntleigh AB Main Business
Table 122. ArjoHuntleigh AB Latest Developments
Table 123. Argon Medical Devices Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 124. Argon Medical Devices Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 125. Argon Medical Devices Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Argon Medical Devices Main Business
Table 127. Argon Medical Devices Latest Developments
Table 128. DaeSung Maref Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 129. DaeSung Maref Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 130. DaeSung Maref Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. DaeSung Maref Main Business
Table 132. DaeSung Maref Latest Developments
Table 133. ALN Implants Chirurgicaux Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 134. ALN Implants Chirurgicaux Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 135. ALN Implants Chirurgicaux Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. ALN Implants Chirurgicaux Main Business
Table 137. ALN Implants Chirurgicaux Latest Developments
Table 138. Lifetech Scientific Basic Information, Venous Thromboembolism Therapy Manufacturing Base, Sales Area and Its Competitors
Table 139. Lifetech Scientific Venous Thromboembolism Therapy Product Portfolios and Specifications
Table 140. Lifetech Scientific Venous Thromboembolism Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Lifetech Scientific Main Business
Table 142. Lifetech Scientific Latest Developments
List of Figures
Figure 1. Picture of Venous Thromboembolism Therapy
Figure 2. Venous Thromboembolism Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Venous Thromboembolism Therapy Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Venous Thromboembolism Therapy Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Venous Thromboembolism Therapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Non-Segmented Pneumatic Compression Pumps
Figure 10. Product Picture of Segmented Pneumatic Compression Pumps without Gradient
Figure 11. Global Venous Thromboembolism Therapy Sales Market Share by Type in 2022
Figure 12. Global Venous Thromboembolism Therapy Revenue Market Share by Type (2018-2023)
Figure 13. Venous Thromboembolism Therapy Consumed in Hospitals
Figure 14. Global Venous Thromboembolism Therapy Market: Hospitals (2018-2023) & (K Units)
Figure 15. Venous Thromboembolism Therapy Consumed in Clinics
Figure 16. Global Venous Thromboembolism Therapy Market: Clinics (2018-2023) & (K Units)
Figure 17. Venous Thromboembolism Therapy Consumed in Others
Figure 18. Global Venous Thromboembolism Therapy Market: Others (2018-2023) & (K Units)
Figure 19. Global Venous Thromboembolism Therapy Sales Market Share by Application (2022)
Figure 20. Global Venous Thromboembolism Therapy Revenue Market Share by Application in 2022
Figure 21. Venous Thromboembolism Therapy Sales Market by Company in 2022 (K Units)
Figure 22. Global Venous Thromboembolism Therapy Sales Market Share by Company in 2022
Figure 23. Venous Thromboembolism Therapy Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Venous Thromboembolism Therapy Revenue Market Share by Company in 2022
Figure 25. Global Venous Thromboembolism Therapy Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Venous Thromboembolism Therapy Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Venous Thromboembolism Therapy Sales 2018-2023 (K Units)
Figure 28. Americas Venous Thromboembolism Therapy Revenue 2018-2023 ($ Millions)
Figure 29. APAC Venous Thromboembolism Therapy Sales 2018-2023 (K Units)
Figure 30. APAC Venous Thromboembolism Therapy Revenue 2018-2023 ($ Millions)
Figure 31. Europe Venous Thromboembolism Therapy Sales 2018-2023 (K Units)
Figure 32. Europe Venous Thromboembolism Therapy Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Venous Thromboembolism Therapy Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Venous Thromboembolism Therapy Revenue 2018-2023 ($ Millions)
Figure 35. Americas Venous Thromboembolism Therapy Sales Market Share by Country in 2022
Figure 36. Americas Venous Thromboembolism Therapy Revenue Market Share by Country in 2022
Figure 37. Americas Venous Thromboembolism Therapy Sales Market Share by Type (2018-2023)
Figure 38. Americas Venous Thromboembolism Therapy Sales Market Share by Application (2018-2023)
Figure 39. United States Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Venous Thromboembolism Therapy Sales Market Share by Region in 2022
Figure 44. APAC Venous Thromboembolism Therapy Revenue Market Share by Regions in 2022
Figure 45. APAC Venous Thromboembolism Therapy Sales Market Share by Type (2018-2023)
Figure 46. APAC Venous Thromboembolism Therapy Sales Market Share by Application (2018-2023)
Figure 47. China Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Venous Thromboembolism Therapy Sales Market Share by Country in 2022
Figure 55. Europe Venous Thromboembolism Therapy Revenue Market Share by Country in 2022
Figure 56. Europe Venous Thromboembolism Therapy Sales Market Share by Type (2018-2023)
Figure 57. Europe Venous Thromboembolism Therapy Sales Market Share by Application (2018-2023)
Figure 58. Germany Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Venous Thromboembolism Therapy Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Venous Thromboembolism Therapy Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Venous Thromboembolism Therapy Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Venous Thromboembolism Therapy Sales Market Share by Application (2018-2023)
Figure 67. Egypt Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Venous Thromboembolism Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Venous Thromboembolism Therapy in 2022
Figure 73. Manufacturing Process Analysis of Venous Thromboembolism Therapy
Figure 74. Industry Chain Structure of Venous Thromboembolism Therapy
Figure 75. Channels of Distribution
Figure 76. Global Venous Thromboembolism Therapy Sales Market Forecast by Region (2024-2029)
Figure 77. Global Venous Thromboembolism Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Venous Thromboembolism Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Venous Thromboembolism Therapy Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Venous Thromboembolism Therapy Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Venous Thromboembolism Therapy Revenue Market Share Forecast by Application (2024-2029)
| ※参考情報 静脈血栓塞栓症（VTE）は、深部静脈血栓症（DVT）および肺塞栓症（PE）が含まれる病態であり、血液が静脈内で異常に固まり、血栓を形成することによって引き起こされます。この病気は、全球規模で見ても重要な健康問題であり、特に入院患者や手術後の患者において高い発症率を持つことが知られています。VTEは、その特性上、一次予防や早期の治療が極めて重要であり、適切な管理を行うことが患者の予後を大きく改善する要因となります。 深部静脈血栓症は、主に下肢の深部静脈に血栓が形成されることで発症します。この血栓が断片化し、血流に乗って肺に到達すると、肺塞栓症を引き起こすことになります。VTEは無症状の場合も多いため、早期の発見が難しいことが多く、治療が遅れると合併症や死亡のリスクが高まることが特徴です。特に高リスク患者に対しては、予防的な治療が推奨されます。 VTEの予防には、薬物療法と非薬物療法の2つのアプローチがあります。非薬物療法としては、圧迫ストッキングの使用や、早期の動き出しが挙げられます。特に手術後や長時間の安静が必要な患者では、脚の静脈ポンプ効果を促進するために、圧迫ストッキングが非常に有効です。一方、薬物療法においては、抗凝固薬の使用が中心となります。これには、ワルファリン、ヘパリン、直接経口抗凝固薬（DOACs）などが含まれ、それぞれの患者の状態やリスクに応じた選択が重要です。 治療においては、まず静脈血栓が形成される原因を特定し、それに基づいた適切なアプローチが求められます。たとえば、手術を受けた患者やがん患者では、特にVTEのリスクが高まるため、それに対して前もって防止策を講じることが必要です。また、妊娠中の女性やオピオイドの長期使用などもリスク因子として知られています。 VTEの治療においては、抗凝固療法が標準的な選択肢となりますが、場合によっては血栓除去術やフィルター挿入といった外科的介入が必要となることもあります。特に大量の肺塞栓が疑われる場合には、緊急に血栓除去を行う場合があります。このように、VTEの治療は症例によって柔軟に対応することが求められ、医療者は各患者のリスク評価を行いながら治療方針を決定しなければなりません。 現在、VTEに対する新しい治療法や技術の開発も進んでおり、例えば、血栓溶解薬や新型の抗凝固薬の研究が盛んに行われています。最近では、特に即効性のある抗凝固薬や、副作用の少ない薬剤の開発が進展しており、治療の選択肢が広がりつつあります。また、近年では、AIや機械学習を利用した診断支援システムも提案されており、これにより更なる早期診断や治療計画の最適化が期待されています。 さらに、患者教育もVTE管理の重要な要素です。患者自身がVTEのリスク要因や予防法について理解し、日常生活での適切な行動を取ることが求められます。特に、手術や入院を控える患者に対しては、事前にしっかりとした情報提供とカウンセリングを行うことが、VTE予防につながります。 最後に、VTEは重篤な合併症を引き起こす可能性があるため、医療従事者のみならず患者自身やその家族も含めた総合的なアプローチが必要です。専門的な知識と経験を持つ医療チームによる協働と、患者に対する適切な教育が、VTEの発症リスクを低下させ、患者の質の高い生活を支えるために不可欠であるといえるでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
